AlphaGenome identifies a deep intronic variant in a family with PLA2G6-associated neurodegeneration: Closing the diagnostic gap in rare genetic diseases
Authors:
- Sarah J EgerSESarah J Eger
- Greizy LópezGLGreizy López
- Luisa Fernanda Gómez NavarroLNLuisa Fernanda Gómez Navarro
- Andrés Peña-TauberAPAndrés Peña-Tauber
- J Nicholas CochranJCJ Nicholas Cochran
- Susan M HiattSHSusan M Hiatt
- Nancy GelvezNGNancy Gelvez
- Milena García-GarcíaMGMilena García-García
- Samuel LoboSLSamuel Lobo
- Michael D GreiciusMGMichael D Greicius
- Diana Lucía MatallanaDMDiana Lucía Matallana
- Juliana Acosta-UribeJAJuliana Acosta-Uribe
Preprint
Abstract
A molecular diagnosis remains out of reach for a substantial subset of patients with clinically recognizable Mendelian disorders, even after comprehensive next-generation sequencing. Causal variants in non-coding regions are difficult to detect and interpret using standard pipelines. Deep intronic variants that disrupt splicing are a known but underexplored source of pathogenic alleles, and systematic tools to evaluate them at scale have only recently emerged. We aimed to resolve an incomplete genetic diagnosis in two siblings with early-onset parkinsonism, prominent neuropsychiatric features, and autonomic dysfunction consistent with PLA2G6 -associated neurodegeneration (PLAN), an autosomal recessive condition. Prior clinical exome sequencing, genome sequencing, Multiplex Ligation-dependent Probe Amplification (MLPA), and long-read sequencing had identified only a single heterozygous PLA2G6 missense variant, c.2132C>G (p.Pro711Arg). We used AlphaGenome to score 91 non-coding variants shared among the affected siblings and their father within 1 megabase of the PLA2G6 locus. The deep-learning model identified an intronic variant (c.2034+355G>A) that was predicted to create a cryptic splice acceptor site that could result in inclusion of a 160-bp cryptic exon. Tissue-specific predictions indicated the aberrant splicing would be detectable in blood, confirmed by junction-spanning RNA-seq reads from an unrelated carrier. This analysis completed a compound heterozygous PLAN diagnosis nearly two decades after symptom onset and demonstrates the utility of sequence-to-function models. Systematic integration of tools like AlphaGenome into rare disease workflows offers a practical, low-barrier route to closing the diagnostic gap for patients with compelling Mendelian phenotypes and incomplete genetic diagnoses.Keywords
Funding Information
- Alzheimer's Association
- Rainwater Charitable Foundation–Tau Consortium
- Bluefield Project to Cure Frontotemporal Dementia
- Global Brain Health Institute
- American Heart Association (26PRE1545631)
This publication has 23 references indexed in Scilit:
- Beyond the exome: What’s next in diagnostic testing for Mendelian conditionsThe American Journal of Human Genetics, 2023
- Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic diseaseMolecular Genetics & Genomic Medicine, 2022
- Dissecting the Phenotype and Genotype of PLA2G6‐Related ParkinsonismMovement Disorders, 2021
- Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson’s disease with brain iron accumulation through pseudo-exon activationneurogenetics, 2021
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic EpilepsiesThe American Journal of Human Genetics, 2018
- Early Ataxia and Subsequent Parkinsonism: PLA2G6 Mutations Cause a Continuum Rather Than Three Discrete PhenotypesMovement Disorders Clinical Practice, 2016
- Novel PLA2G6 mutations associated with an exonic deletion due to non-allelic homologous recombination in a patient with infantile neuroaxonal dystrophyHuman Genome Variation, 2015
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyThe Lancet Neurology, 2011
- MultipleLRRK2variants modulate risk of Parkinson disease: a Chinese multicenter studyHuman Mutation, 2010